HomeMTNB • NYSEAMERICAN
add
Matinas BioPharma Holdings Inc
Previous close
$0.79
Day range
$0.79 - $0.91
Year range
$0.47 - $3.09
Market cap
5.73M USD
Avg Volume
25.15K
P/E ratio
-
Dividend yield
-
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 1.58M | -26.38% |
Net income | -1.53M | 64.16% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -1.58M | 63.23% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 5.44M | -49.65% |
Total assets | 9.70M | -52.88% |
Total liabilities | 3.24M | -32.58% |
Total equity | 6.46M | — |
Shares outstanding | 6.41M | — |
Price to book | 0.72 | — |
Return on assets | -37.34% | — |
Return on capital | -41.50% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -1.53M | 64.16% |
Cash from operations | -1.47M | 57.89% |
Cash from investing | 320.00K | -96.68% |
Cash from financing | 64.00K | 195.52% |
Net change in cash | -1.09M | -117.93% |
Free cash flow | -414.62K | 76.94% |
About
Founded
2013
Headquarters
Website
Employees
3
